Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» First 90 Days of 2013 Are Live or Die For These Biotech Stocks
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
Submitted by
admin
on November 19, 2012 - 2:00pm
Source:
TheStreet.com
News Tags:
Oncothyreon
Celsion
Arena Pharmaceuticals
NuPathe
Hemispherx
Amarin
Biogen Idec
Gilead
Hyperion Therapeutics
Celgene
Raptor Pharmaceuticals
Dynavax
Zogenix
Impax Labs
Headline:
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
Do Not Allow Advertisers to Use My Personal information
